RNS Number : 8573U
Acambis PLC
20 May 2008
Shareholders approve unanimously Acambis' £40m (net) Placing and Open Offer at EGM
FOR PUBLICATION IN THE UNITED KINGDOM ONLY. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION
DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART,
IN, INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA AND JAPAN, OR INTO ANY OTHER
JURISDICTION WHERE THE EXTENSION OR AVAILABILITY OF THE
PLACING AND OPEN OFFER OR DISTRIBUTION OF THIS ANNOUNCEMENT WOULD BREACH ANY APPLICABLE LAW
Cambridge, UK and Cambridge, Massachusetts - 20 May 2008 - Acambis plc (LSE: ACM)
("Acambis" or the "Company"), a vaccine development
company, announces that the Placing and Open Offer announced on 23 April 2008 was approved
unanimously today at an Extraordinary General
Meeting ("EGM") of shareholders.
Acambis announced on 23 April 2008 that it was proposing to raise approximately £40m,
net of expenses, through an underwritten Placing
and Open Offer of 37,715,811 New Ordinary Shares at a price of 115 pence per New Ordinary
Share. At the EGM held earlier today, all the
Resolutions that were set out in the Notice of EGM included in the Prospectus published on 23
April 2008 were duly passed. The results of
the Placing and Open Offer were announced on 19 May 2008. The fundraising received strong
support from shareholders.
The final step in the process to complete the Placing and Open Offer is for the New
Ordinary Shares to be admitted to trading on the
London Stock Exchange and to listing on the Official List of the UK Listing Authority, which
is expected to become effective tomorrow (21
May 2008).
Peter Fellner, Chairman of Acambis, commented:
"We are delighted to have received such a positive response from our existing shareholders
and look forward to welcoming our new
investors when the Placing and Open Offer process completes later this week. With the $425
million US Government contract now in place and
the £40m fundraising completed, we believe Acambis has the innovative products, the
pipeline and the funding to create significant value
for shareholders in the coming years."
Capitalised terms used (but not defined) in this announcement have the same meanings as in
the Prospectus sent to shareholders on 23
April 2008 unless the context requires otherwise.
Enquiries
Acambis plc +44 (0) 1223 275 300
Ian Garland / Elizabeth Jones / Lyndsay Wright
JPMorgan Cazenove Limited +44 (0) 20 7588 2828
John Muncey / James Mitford / Shona Graham
Piper Jaffray +44 (0) 20 3142 8700
Neil Mackison / Jamie Adams
Brunswick +44 (0) 20 7404 5959
Jon Coles / Justine McIlroy / Annabel Entress
JPMorgan Cazenove Limited, which is authorised and regulated in the United Kingdom by the
Financial Services Authority, is acting for
the Company as sponsor, joint broker and joint underwriter in connection with the Placing and
Open Offer and not for any other person and
will not be responsible to any other person for providing the protections afforded to its
customers or for providing advice in relation to
the Placing and Open Offer, the contents of the Prospectus and, if relevant, the accompanying
documents or any arrangements referred to
therein or in this announcement.
Piper Jaffray Ltd., which is authorised and regulated in the United Kingdom by the
Financial Services Authority, is acting for the
Company as joint broker and joint underwriter in connection with the Placing and Open Offer
and not for any other person and will not be
responsible to any other person for providing the protections afforded to its customers or for
providing advice in relation to the Placing
and Open Offer, the contents of the Prospectus and, if relevant, the accompanying documents or
any arrangements referred to therein or in
this announcement.
This announcement has been issued by Acambis plc and is the sole responsibility of Acambis
plc.
The Existing Ordinary Shares, the New Ordinary Shares and the Basic Entitlements have not
been and will not be registered under the US
Securities Act of 1933, as amended and may not be offered, sold, pledged, transferred or
otherwise disposed of except outside the United
States in an "offshore transaction" (as defined in Rule 902(k) of the US Securities Act) in
accordance with Rule 903 or 904 of Regulation S
under the US Securities Act; pursuant to an effective registration statement under the US
Securities Act or pursuant to an available
exemption from the registration requirements of the US Securities Act. Moreover, neither the
Existing Ordinary Shares, nor the New Ordinary
Shares nor the Basic Entitlements have been or will be registered under the securities laws of
any state of the United States, or under the
applicable securities laws of Australia, Canada or Japan, or in any other jurisdiction where
action for that purpose is required. Subject to
certain exceptions, the New Ordinary Shares made available under the Placing and Open Offer
may not be offered, sold, delivered or transferred in or into the United States, Australia,
Canada or
Japan. This announcement should not be issued, mailed or otherwise distributed or sent into
the United States, Australia, Canada or Japan.All persons (including, without limitation, stockbrokers, banks or other agents) must observe
these restrictions.
This announcement does not constitute or form part of any offer or invitation to sell or
issue, or any solicitation of any offer to
purchase or subscribe for, any securities.
The delivery of this announcement shall not, under any circumstances, create any
implication that there has been no change in the
affairs of the Group since the date of this announcement nor that the information in it is
correct as of any subsequent time.
This announcement may contain forward-looking statements that reflect the Group's current
expectations regarding future events. Such
forward-looking statements are based on current expectations and on numerous assumptions
regarding the Group's present and future business
strategies and the environment in which the Group will operate in the future, and are subject
to risks and uncertainties that could cause
actual results to differ materially from those expressed or implied by those statements. The
Company disclaims and assumes no responsibility
to update or revise any of the forward-looking statements contained in this announcement to
reflect any change in the Company's expectations
or any change in events, conditions or circumstances on which any such statement is based.
This information is provided by RNS
The company news service from the London Stock Exchange
END
EGMIIFSAEAIIFIT
|